Month: August 2025
-
BREAKING: GSK cashes in on license deal as CureVac settles U.S. patent dispute with acquirer BioNTech and Pfizer for $790M+
Pfizer and BioNTech have settled their three-year COVID vaccine-related patent infringement dispute with CureVac in the U.S., granting the latter and its licensing partner GSK $370 million each.
-
NPEs file as few as 10% of ITC Section 337 complaints: agency counsel
Between 70% and 90% of ITC investigations are initiated by non-NPEs, with those numbers generally increasing, while there is a notable shift in the NPEs that do file complaints toward being more innovation-focused.
-
Chinese court enforces $73 million U.S. judgment: door opens for more foreign order enforceability, including UPC
A Chinese order enforcing a U.S. judgment based on reciprocity could mean the Unified Patent Court will no longer require Chinese companies to pay collateral, with the increased possibility that UPC judgments will now be enforced in China too.
-
Access Advance extends early-bird period for video streaming patent license to September 30, 2025: service announcement
The early-bird period for implementers taking a license to Access Advance’s Video Distribution Pool has been extended to September 30.
-
Gallium nitride patent wars: Munich I Regional Court grants Infineon second injunction against Innoscience
The pendulum has swung back in favor of Infineon in its long-running dispute against Innoscience over gallium nitride technology.
-
With UPC lawsuit against Transsion, Huawei joins fellow Access Advance licensors NEC, JVC, Sun Patent Trust in HEVC SEP enforcement
After settling with Philips over other standards and taking a Via LA pool license (its first pool license ever), Transsion could demonstrate that regional rates indeed facilitate license deals.
-
Chanel sued over augmented reality patent in Western District of Texas: virtual try-on
Zugara’s patent suit against Chanel is the latest in a string of infringement disputes in the Augmented Reality industry and the second targeting virtual try-on technologies in the beauty sector.
-
An interview with Bayer’s outgoing head of IP Dr. Jörg Thomaier, new head Dorian Immler
Following three decades at Bayer, Dr. Jörg Thomaier is retiring as head of IP, super confident that his replacement Dorian Immler will have the energy and drive to make the changes that the department needs to keep prospering.
-
UPC Roundup: timeliness of sealing requests; non-novelty and non-inventiveness over same art; Samsung defends twice; new cases (also OpenAI)
This is a summary of developments in and around the Unified Patent Court (UPC) in the week since our July 26, 2025, UPC Roundup. 1. CoA: trade secrets must be timely protected (Strabag v. Swarco Futurit) In a decision dated August 1, 2025 (PDF), the Court of Appeal (CoA) rejected the applications submitted by Strabag and…
-
UPC gets world’s first serious patent lawsuit against OpenAI: French company alleges infringement by C2PA content authenticity standard
In June, the UPC received not only a record number of cases, but also a number of very high-profile ones.